Hostname: page-component-7b7567c8c-2n9c9 Total loading time: 0 Render date: 2026-11-14T17:00:34.675Z Has data issue: false hasContentIssue false
  • English
  • Français

The Jenner bicentenary; still uses for smallpox vaccine

Published online by Cambridge University Press:  15 May 2009

Derrick Baxby
Derrick Baxby
Affiliation:
Department of Medical Microbiology, University of Liverpool, Liverpool L69 3BX, UK
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'

Information

Type
Editorial
Information
Epidemiology & Infection , Volume 116 , Issue 3 , June 1996, pp. 231 - 234
Copyright
Copyright © Cambridge University Press 1996

References

REFERENCES

1.Jenner, E. An inquiry into the causes and effects of the variolae vaccinae. London: Sampson Low, 1798.Google Scholar
2.Baxby, D. The genesis of Edward Jenner's Inquiry of 1798; a comparison of the two unpublished manuscripts and the published version. Med Hist 1985; 29 193–9.CrossRefGoogle ScholarPubMed
3.The Jenner centenary number. BMJ 1896; i: 1245–312.Google Scholar
4.Plotkin, S, Fantini, B, eds. Vaccinia, vaccination, vaccinology: Jenner, Pasteur, and their successors. Paris: Elsevier, 1996.Google Scholar
5.Pastoret, PP, Brochier, B. The development and use of a vaccinia-rabies recombinant oral vaccine for the control of wildlife rabies: a link between Jenner and Pasteur. Epidemiol Infect 1996; 116: 235–240.CrossRefGoogle ScholarPubMed
6.Limbach, KJ, Paoletti, E. Non-replicating expression vectors: applications in vaccine development and gene therapy. Epidemiol Infect 1996; 116: 241–256.CrossRefGoogle ScholarPubMed
7.Baxby, D. Jenner's smallpox vaccine: the riddle of vaccinia virus and its origin. London: Heinemann Educational Books, 1981.Google Scholar
8.Jenner, E. Further observations on the variolae vaccinae. London: Shury, 1799.Google ScholarPubMed
9.Dixon, CW. Smallpox. London: Churchill, 1962.Google Scholar
10.Fenner, F, Henderson, DA, Arita, I, Jezek, Z, Ladnyj, ID. Smallpox and its eradication. Geneva: WHO, 1988.Google Scholar
11.Panicali, D, Paoletti, E. Construction of poxviruses as cloning vectors: insertion of the thymidine kinase gene from herpes simplex virus DNA into the DNA of infectious vaccinia virus. Proc Soc Natl Acad Sci USA 1982; 79: 7415–9.CrossRefGoogle ScholarPubMed
12.Binns, M, Smith, GL, eds. Recombinant poxviruses. Boca Raton: CRC Press, 1992.Google Scholar
13.Baxby, D. Recombinant poxvirus vaccines. Rev Med Microbiol 1993; 4: 80–8.CrossRefGoogle Scholar
14.Yilma, T, Hsu, D, Jones, L et al. , Protection of cattle against rinderpest with infectious vaccinia virus recombinants expressing the HA or F genes. Science 1988; 242: 1058–61.CrossRefGoogle Scholar
15.Baxby, D. Indications for smallpox vaccine: policies still differ. Vaccine 1993; 11: 395–6.CrossRefGoogle ScholarPubMed
16.Baxby, D, Gaskell, RM, Gaskell, CJ, Bennett, M. Ecology of orthopoxviruses and use of recombinant vaccinia vaccines. Lancet 1986; ii: 850–1.CrossRefGoogle Scholar
17.Tartaglia, J, Perkus, M, Taylor, J et al. , NYVAC: a highly attenuated strain of vaccinia virus. Virology 1992; 188: 217–32.CrossRefGoogle ScholarPubMed
18.Esposito, JJ, Sumner, JW, Brown, D et al. , Raccoon poxvirus rabies-glycoprotein oral vaccine for wildlife; further efficacy studies and serosurvey for raccoon poxvirus. In: Brown, F, Chanock, RM, Ginsberg, H, Lerner, RA, eds. Vaccine '92. Cold Spring Harbor; Cold Spring Harbor Press, 1992; 321–9.Google Scholar
19..Romero, CH, Barrett, T, Chamberlin, RW et al. , Recombinant capripoxvirus expressing the hemagglutinin protein gene of rinderpest virus: protection of cattle against rinderpest and lumpy skin disease viruses. Virology 1994; 204: 425–9.CrossRefGoogle ScholarPubMed
20.Taylor, J, Weinberg, R, Langhett, B, Desmettre, P, Paoletti, E. Recombinant fowlpox virus induces protective immunity in non-avian species. Vaccine 1988; 6: 497–503.CrossRefGoogle ScholarPubMed
21.Cadoz, M, Strady, A, Meignier, B et al. , Immunization with canarypox virus expressing rabies glycoprotein. Lancet 1992; 339: 1429–32.CrossRefGoogle ScholarPubMed
22.Baxby, D, Paoletti, E. Potential use of non-replicating vectors as recombinant vaccines. Vaccine 1992; 10: 8–9.CrossRefGoogle ScholarPubMed